Dara Azar

Stock Analyst at Stifel

(2.40)

# 0

Out of 0 analysts

2

Total ratings

100%

Success rate

16.65%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dara Azar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SMMT Summit Therapeutics	Initiates: Buy	$45	$25.15	+78.93%	1	Apr 8, 2026
	INBX Inhibrx Biosciences	Initiates: Buy	$150	$88.23	+70.01%	1	Apr 8, 2026

Summit Therapeutics

Apr 8, 2026

Initiates: Buy

Price Target: $45

Current: $25.15

Upside: +78.93%

Inhibrx Biosciences

Apr 8, 2026

Initiates: Buy

Price Target: $150

Current: $88.23

Upside: +70.01%